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Abstract  
Purpose of Review 
This systematic review describes evidence concerning medicinal plants that, in addition to 
exerting hypoglycemic effects, decrease accompanying complications such as nephropathy, 
neuropathy, retinopathy, hypertension and/or hyperlipidemia. 
Recent Findings 
Studies on the antidiabetic mechanisms of medicinal plants have shown that most of them 
produce hypoglycemic activity by: stimulating insulin secretion, augmenting peroxisome 
proliferator-activated receptors (PPARs), inhibiting α-amylase or α-glucosidase, inhibiting 
the secretion of glucagon-like peptide-1 (GLP-1), inhibiting advanced glycation end product 
(AGE) formation, free radical scavenging plus antioxidant activity (against reactive oxygen- 
or nitrogen- species: ROS/RNS) up-regulating or elevating translocation of glucose 
transporter type 4 (GLUT-4) and preventing development of insulin resistance.  
Summary 
Not only are medicinal plants effective in diabetes mellitus, but many of them also possess a 
variety of effects on other disease states, including the complications of diabetes. Such plants 
may be appropriate alternatives or adjuncts to available antidiabetic medications. 
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INTRODUCTION 
Diabetes mellitus (DM) is one of the most common endocrine diseases worldwide, and the 
number of diabetics was recorded as 422 million in 2014. [1]. Type 1 DM is caused by 
impaired insulin secretion, while type 2 DM is related to progressive insulin resistance in the 
liver and peripheral tissues, as well as relative insulin deficiency [2].  
DM along with impaired glucose tolerance is a life-threatening illness that increases the risk 
of cardiovascular disease by as much as 8 times. The disease accounts for 60% of non-
invasive amputations in the United States [3] and in 2015, 30.3 million Americans, were 
regarded to have DM, 7.2 million of which, were thought to be undiagnosed [4]. In the same 
year, an estimated 1.6 million deaths were directly attributed to diabetes and a further 2.2 
million deaths were ascribed to high blood glucose [5]. It was also estimated that, by the 
year 2040, the number adult diabetics would increase to 642 million globally [6]. Higher-
than-optimal blood glucose caused deaths, by increasing the risks of cardiovascular and 
other diseases. Forty-three percent of these deaths occurred before the age of 70 years [1].  
Hyperglycemia causes an increase in oxidative stress, resulting in inflammation, activation 
of the polyol pathway, and damage to various organs of the body [7,8]. Diabetes requires 
diagnosis accompanied by medical management with lifestyle modification although 
currently, no successful causal treatment has been discovered. There are many synthetic 
drugs for the symptomatic treatment of DM, but none of them are able to definitively 
alleviate the disease origin [9]. Common symptomatic treatments include regular injection of 
insulin or oral administration of antidiabetic drugs, such as sulfonylureas, α-glucosidase 
inhibitors, biguanides, thiazolidinediones, dipeptidyl peptidase-4 (DPP4) inhibitors, sodium-
glucose co-transporter-2 (SGLT2) inhibitors, glinides, and parenteral administration of 
glucagon-like peptide-1 (GLP-1) agonists, which can cause moderate to severe side effects 
[10]. As a result, alternative treatments are urgently needed for more effective management 
of the disease. 
 Complementary and alternative medicine (CAM) is increasingly being used as a diabetic 
management strategy. In this context, traditional herbal medicine is used across the world for 
disease treatment [11]. The World Health Organization has recommended that clinicians use 
herbal drugs to treat DM in addition to its complications. There is no ultimate method 
available to prevent and treat DM, but strategies are needed to reduce the complications 
brought about by the disease [12, 13]. Some medicinal plants with antioxidant properties are 
useful for reducing oxidative stress and its adverse effects [14, 15] and nowadays, some of 
the available drugs are plant-based [16]. Research has shown that a number of antidiabetic 
plants, apart from their hypoglycemic activity, have other useful properties such as 
antihypertensive, nephroprotective and retinoprotective activities which may be useful 
against the most common complications of DM. Thus, consumption of these plants may well 
be exploited in the control of DM and its complications [17, 18]. Hence, the purpose of this 
article is to systematically review the medicinal plants that are useful in the management of 
DM and its accompanying complications.   
 
MATERIALS AND METHODS 
To conduct this review, firstly the complications caused by DM were addressed. 
Subsequently, underlying antidiabetic mechanisms of medicinal plants were reviewed under 
general thematic headings. For this purpose, the articles indexed in PubMed, Scopus, Web of 
Science, MEDLINE, Google Scholar, Web of Science (SCOPUS), EBSCO Academic Search, 
Cochrane Central Register of Controlled Trials (CENTRAL), and the Chinese Network 
Knowledge Infrastructure (CNKI) and published prior to 2018 were retrieved using the 
keywords “hypertension”, “retinopathy”, “neuropathy”, and “nephropathy” or “medical 
plants for diabetic hypertension or retinopathy or nephropathy or neuropathy” were 
reviewed. Articles containing plants affecting one or more of the above items were selected. 
A total of 36,000 publications were retrieved by the first selection process. Out of these 
publications, 305 articles identified in which medical plants were examined against DM 
and/or diabetic complications (hypertension, retinopathy, nephropathy, neuropathy and/or 
hyperlipidemia). After a more detailed review of these articles, 89 relevant papers were 
selected and their applicable findings summarized in tabular form. 
   
RESULTS 
Medicinal herbs effective on diabetes:  
The use of antioxidants and the reduction and control of blood glucose significantly reduce 
the complications associated with DM [19, 20]. Consequently, medicinal plants with 
antioxidant properties are employed to restrict oxidative stress and its adverse effects [21, 
22]. A number of medicinal plants with antidiabetic and antihyperlipidemic effects are 
known to be effective in preventing and treating DM.  
Antidiabetic plant mechanisms  
There are several fundamental modes of action for natural products in DM [23]. The 
principal mechanisms include those that act by: stimulating insulin secretion, augmenting 
peroxisome proliferator-activated receptors (PPARs), inhibiting α-amylase or α-glucosidase, 
inhibiting the secretion of the incretin, glucagon-like peptide-1 (GLP-1), inhibiting advanced 
glycation end product (AGE) formation, free radical scavenging plus antioxidant activity 
(against reactive oxygen- or nitrogen- species: ROS/RNS) up-regulating or elevating 
translocation of glucose transporter type 4 (GLUT-4) and preventing development of insulin 
resistance (Figure 1).  
 
 
Figure 1. Diagram depicting some of the principle plant-derived mechanisms of antidiabetic 
activity. 
          GLUT-4 = Insulin-regulated glucose transporter type 4; ROS = Reactive oxygen 
species;  
                RNS = Reactive nitrogen species; AGE = Advanced glycation end products; 
                DPP4 = Dipeptidyl peptidase; GLP-1 = Glucagon-like peptide-1 (incretin);  
                PPARs = Peroxisome proliferator-activated receptors 
 
Insulin secretagogues  
 Some plants or their constituents stimulate insulin secretion. They include: Panax ginseng 
[24] and the diosgenin component in Fenugreek (Trigonella foenum graecum) [25, 26, 27] 
which also increases glucose metabolism not only by stimulating adipocyte differentiation 
but also via a reduction of inflammation in adipocytes [28]. There is in addition, an insulin 
secretagogic action of the compound S-methyl cysteine sulfoxide which has been isolated 
from the onion plant (Allium cepa) [29].  
Increased expression of peroxisome proliferator-activated receptors (PPARs) 
In bitter melon (Momordica charantia L.), 9cis, 11trans, 13trans-conjugated linolenic has 
been found to activate PPARalpha in rat tissues [30]. In addition, momordin extracted from 
bitter melon, increases the expression of human PPARdelta mRNA and the production and 
activation of PPARdelta is further upregulated through PPARdelta promoter activity [31]. 
α-Amylase and α-glucosidase inhibition  
Azadirachtolide, isolated from Azadirachta indica (also known as Neem tree) has been 
shown to exhibit anti-hyperglycaemic and anti-lipidemic actions in diabetic rats. 
Furthermore, an inhibitory activity of azadirachtolide on α-amylase and α-glucosidase has 
been demonstrated, suggesting that this A.  indica constituent is potentially beneficial in the 
management of diabetes associated with an abnormal lipid profile coupled with related 
cardiovascular complications [32]. Moreover, the limonoids azadiradione and gedunin plus 
the tetranortriterpenoid compound meliacinolin isolated from A. indica, are also inhibitory 
on both α-amylase and α-glucosidase further indicating that this medicinal plant has a 
propensity to reduce post-prandial hyperglycemia in the diabetic condition [33, 34]. 
Additionally, extracts from cinnamon bark species possess inhibitory activity against 
intestinal α-glucosidase and pancreatic α-amylase [35] and even after chronic extract 
administration, α-glucosidase activity remains at a low level, so this natural product has 
promise in DM [36]. What is more, an extract of onion (A. cepa) containing the phenolic 
compound quercetin, also possesses α-glucosidase inhibitory activity [37]. 
Increased glucagon-like peptide-1 (GLP-1) secretion 
It has been demonstrated in vitro and in vivo that the saponin ginsenosides present in P. 
ginseng stimulate GLP-1 secretion and this incretin reduces hyperglycemia significantly 
contributing towards an antidiabetic effect [38]. Apart from P. ginseng, other medicinal 
plants including Anemarrhena asphodeloides, Citrus aurantium, Bupleurum falcatum and 
Gentiana scabra also have GLP-1 secretogogic activity [39]. 
Inhibition of advanced glycation end-product (AGE) formation 
Advanced glycation end-products (AGEs) cause inflammation and have a crucial role in 
generating diabetic complications. In light of this, catalpol isolated from Rehmannia 
glutinosa restrains AGE-mediated inflammation by inhibiting ROS production and NADPH-
oxidase activity and this is considered to prevent AGE-mediated problems in DM [40]. An 
extract from A. indica also inhibits AGE formation in addition to oxidative stress and it is 
thought to have a protective effect in diabetic kidney disease [41]. Similarly, a Piper auritum 
leaf extract has been reported to have concomitant antioxidant as well as AGE inhibitory 
activities [42]. 
 
 
Free radical scavenging activity 
An extract from R. glutinosa rhizome displayed free radical scavenging activity reducing the 
level of ROS intracellularly in addition to diminishing pro-inflammatory gene expression 
and this finding, has been advocated as a therapeutic possibility for DM [43]. Likewise, T. 
foenum graecum (Fenugreek) seeds boost antioxidant status in the blood suggesting that 
perturbed free radical metabolism in the diabetic condition may be returned to normal [44]. 
It is of note in this regard, that a range of other plants used to treat diabetes, exhibit activity 
in the DPPH (2, 2-Diphenyl-1-picrylhydrazyl) test for free radical scavengers [42].  
Reduction of antioxidant/ROS/RNS activity 
Invariably, studies on free radical scavengers are performed in the context of antioxidant 
activity. Thus, R. glutinosa has strong free radical scavenging effects which are coincident 
with a reduced production of ROS [43] and this is attributable to catalpol [40]. Fenugreek 
increases lipid peroxidation and blood antioxidants in diabetic rats [44] and its constituent 
trigonelline, acts by affecting ROS [25] while the steroidal saponin, diosgenin, also present 
in yam (Dioscoreaceae family), modulates oxidative stress [45]. The ginsenoside-Rg1 
component of P. ginseng improves angiogenesis in diabetic ischemic rat hindlimb which is 
believed to be through increased activation of endothelial nitric oxide synthase (eNOS) [46]. 
Another P. ginseng constituent, 20(S)-ginsenoside Rg(3), produces positive effects on 
diabetic renal damage which have been assigned to inhibition of NMDA receptor-mediated 
nitrosative stress [47]. It is also noteworthy that there are other examples of antidiabetic 
plant-induced antioxidant activity [42].  
 
Increased, up-regulation and translocation of glucose transporter type 4 (GLUT-4) 
Glut-4 is one of the most important insulin regulated glucose transporters located at the 
surface membrane of adipocytes, skeletal and cardiac muscle cells. A triterpenoid constituent 
of M. charantia fruit, cucurbitane [48], stimulates GLUT-4 cell membrane translocation to 
facilitate glucose uptake and AMP-activated protein kinase (AMPK) phosphorylation [49-
51]. A comparable effect occurs with an extract of A. cepa [52]. Likewise, in mouse 
adipocytes, an aqueous extract of Cinnamon evokes a biphasic action on GLUT-4 mRNA 
[53] whereas an active constituent of the plant, cinnamaldehyde, increases glucose uptake 
through augmented GLUT4 translocation [54]. Ginsenoside-Rh2 present in P. ginseng 
decreases plasma glucose in diabetic rats by increasing GLUT-4 expression via a more 
indirect mechanism arising from elevated β-endorphin stimulation of µ-opioid receptors 
[55].  
Insulin resistance reduction 
Insulin resistance (IR) is a pathological condition in which cells do not respond normally to 
insulin. In this respect, Ocimum sanctum (Holy basil) delays the onset of insulin resistance in 
rats and has been proposed as an adjuvant therapy for patients who develop this condition 
[56]. Also, in rats, meliacinolin isolated from the leaves of A. indica inhibits insulin 
resistance among a number of other antidiabetic modes of action [34]. Analogously, M. 
Charantia ameliorates insulin resistance in mice though the underlying mechanism has been 
hypothesized to be through PPARgamma-mediated pathways [57]. 
There are over 400 plant species with hypoglycemic properties. However, the study of new 
antidiabetic, plant-derived drugs is still pursued and continues to draw attention because of 
potential safety issues. Most of the plants contain alkaloids, glycosides, terpenoids, 
flavonoids and carotenoids, to which their antidiabetic properties have been attributed. 
Several medicinal plants such as Galega officinalis, in addition to producing positive effects 
on glucose homeostasis in diabetic patients, have found application in preventing and 
treating hypertension, cardiovascular disease, and kidney injury [13, 58, 59, 60]. In addition 
to producing hypoglycemic effects, numerous plants have been demonstrated to be effective 
against the wide range of diabetic complications (Table 1). In Table 2, the mechanisms of 
the effects of these plants are summarized. 
 
CONCLUSION: 
Problems arising from insulin resistance and chronic hyperglycemia have become a major 
concern in clinical science and drug therapy. Medicinal plants have usually attracted 
attention conceivably due to fewer side effects than chemically synthetic drugs. The 
antihyperglycemic effects of the plants presented in this article are essentially related to their 
ability to maintain pancreatic function and insulin output facilitating anabolic activities such 
as muscle, adipocyte and hepatic glucose uptake as well as glucose-to-glycogen conversion. 
Oxidative stress induced by hyperglycemia plays an important role in the expansion of the 
extracellular matrix and glucose-induced collagen production [206]. When endothelial cells 
respond to increased glucose, the production of reactive nitrogen species and ROS increases. 
The production of these reactive substances triggers single-strand breakage of DNA, and 
subsequently increases the levels of 8-hydroxyguanine and 8-hydroxydeoxy guanosine 
(markers of oxidative stress-induced DNA damage) in plasma and tissues. The 
concentrations of these products can be restrained by controlling hyperglycemia and using 
antioxidants [207]. Studies have shown that the use of antioxidants has been successful in 
preventing DM-induced disorders, including neuropathy, nephropathy and retinopathy. High 
doses of single antioxidants, such as vitamin E or vitamin C, may interfere with the 
antioxidant-provident balance in the cellular system, so it has been suggested that a mixture 
of therapeutic antioxidants with trace elements and vitamins may be used to improve the 
metabolic system [208]. More importantly, single antioxidants may not be able to counteract 
all free radical species; hence, medicinal plants which possess a wide range of 
phytochemicals with antioxidant activities may be more efficient.  
Although treatment with medicinal plants has significant effects on pancreatic β-cells 
reducing blood glucose levels as well as other DM-related complications, there is scant 
information on their biology, especially how they actually affect DM. However, it has been 
shown that most medicinal plants contain compounds such as glycosides, alkaloids, 
terpenoids, and flavonoids, which mitigate DM by exerting antioxidant effects and other 
related activities [71-73].  Taken together, although plants may have antidiabetic effects with 
their own specific action mechanism, almost all of them display antioxidant properties and a 
range of other contributory actions. Given that oxidative stress is one of the main causes of 
DM and its related disorders, it is likely that the antioxidant effect of these plants plays a 
major role in their effectiveness. 
Finally, it can be concluded that medicinal plants that produce a profile of concomitant 
effects may be considered as alternative or adjunctive drugs for the treatment or prevention 
of DM and its complications. It is however, essential to study the effects of medicinal plants 
on DM in more detail in order to obtain further data on the biology and pharmacological 
effects of these plants.  
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Table 1: Medicinal plants with multiple functions in diabetes mellitus 
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Family Scientific name 
61     ☑ ☑ Anacardiaceae Anacardium occidentale (Leaf) 
62, 63 ☑ ☑    ☑ Asteraceae Achillea milefolium (Leaf) 
64  ☑    ☑ Malvaceae Althea officinalis (Root) 
65 ☑     ☑ Liliaceae Allium iranicom (Leaf, Bulb) 
66, 67 ☑ ☑    ☑ Liliaceae Allium cepa (Leaf, Bulb) 
68, 69 ☑ ☑   ☑ ☑ Liliaceae Allium sativum (Leaf, Bulb) 
70-75 ☑ ☑    ☑ Liliaceae Aloe vera (Leaf) 
76, 77 ☑ ☑    ☑ Apiaceae Anethum graveolens (Leaf, Seed) 
78    ☑   Umbelliferae Angelica sinensis 
79, 60 ☑ ☑    ☑ Annonaceae Annona squamosa (Leaf) 
61  ☑ ☑ ☑ ☑  Annonaceae Annona muricata (Leaf) 
62-85  ☑   ☑  Fabaceae Astragalus membranaceus 
86, 87 ☑ ☑    ☑ Umbellifera Apium graveolens (Leaf) 
88  ☑    ☑ Compositae Artemisia vulgaris (Leaf) 
65 ☑ ☑    ☑ Compositae Arctium loppa (Root) 
89 ☑ ☑    ☑ Germinaceae Avena sativa (Fruit) 
90, 91 ☑ ☑    ☑ Berberidaceae Berberris vulgaria (Root/Fruit) 
92, 93      ☑ Nyctaginaceae Boerhaavia diffusa (Leaf) 
94  ☑    ☑ Burceraceae Boswellio carteri (Resin) 
95      ☑ Nyctaginaceae Bougainvillea spectabilis (Leaf) 
96      ☑ Euphorbiaceae Bridelia ndellensis (Leaf) 
97-101   ☑  ☑  Green tea Camellia sinensis 
102,103 ☑ ☑   ☑ ☑ Leguminosae Canavalia ensiformis (seeds) 
104-106     ☑ ☑ Flacourtiaceae Casearia esculenta  
107      ☑ Caesalpiniaceae Cassia kleinii (Leaf) 
108  ☑    ☑ Fabaceae Castanospermum austral (seeds) 
109-113    ☑   Solanaceae Capsicum frutescens 
114      ☑ Apocyaceae Catharanthus roseus (Leaf) 
115 ☑ ☑    ☑ Compositae Chicorium intybus (Root) 
116 ☑ ☑    ☑ Rutaceae Citrus limon (Fruit) 
117 ☑ ☑    ☑ Lauraceae Cinnamomum verum (Bark) 
118      ☑ Lauraceae Cinnamonum cassia 
119     ☑  Lauraceae Cinnamomum zeylanicum 
120,121 ☑ ☑    ☑ Rutaceae Citrus aurantium (Fruit) 
122,123 ☑ ☑    ☑ Rutaceae Citrus paradise (Fruit) 
124      ☑ Cucurbitaceae Coccinia indica (Fruit) 
125     ☑  Araceae Colocassia esculenta 
126     ☑ ☑ Menispermaceae Cocculus hirsutus (Leaf) 
127      ☑ Menispermaceae Coscinium fenestratum (Stem)  
65 ☑     ☑ Umbelliferae Coriandrum sativom (Fruit) 
128,129 ☑ ☑    ☑ Cornaceae Cornus mas (Fruit) 
130 ☑ ☑    ☑ Rosaceae Crataegus microphylla (Leaf/Fruit) 
131  ☑    ☑ Cupressaceae Cryptomeria japonica (Leaf) 
132,133 ☑ ☑    ☑ Cucurbitaceae Cucumis melo (Fruit)  
134 ☑ ☑    ☑ Curcubitaceae Curcubita pepo (Fruit) 
135 ☑     ☑ Asteraceae Cynara cardunculus (Flower) 
136,137   ☑   ☑ Zingiberaceae Curcuma longa 
138  ☑    ☑ Umbelliferae Daucus carota (Fruit) 
139  ☑    ☑ Brassiacaceae Descurainia sophia (seeds) 
140  ☑    ☑ Fabaceae Desmodium styracifolium (Flower) 
141,142  ☑    ☑ Dioscoreaceae Dioscorea dumetorum ( Stem) 
125     ☑  Dioscoreaceae Dioscorea cayenensis 
143,144      ☑ Moraceae Ficus hispida (Bark)  
145-147  ☑   ☑   Fish oil 
148     ☑  Ganodermataceae Ganoderma lucidum 
149-152  ☑ ☑  ☑  Ginkgoaceae Ginkgo biloba 
153     ☑  Asclepiadaceae Gymnema montanum 
154  ☑   ☑   Glycine max 
155,156      ☑ Hypoxidaceae Hypoxis hemerocallidea Fisch. Mey. 
157       Juglandaceae Juglans regia 
158,159     ☑ ☑ Linaceae Linum usitatissimum 
160      ☑ Solanacaea Lycium barbarum 
161,161    ☑ ☑  Cucurbitacaea Momordica charantia 
162      ☑ Rutaceae Murraya koenigii Linn 
163    ☑   Onagraceae Oenothera biennis 
164,165     ☑  Oleaceae Olea europaea 
166   ☑    Paeoniaceae Paeonia suffruticosa 
167     ☑ ☑ Araliaceae Panax ginseng (Root) 
168,169     ☑  Araliaceae Panax notoginseng 
170,171   ☑    Pinaceae Pinus pinaster 
172     ☑  Asparagaceae Polygonatum odoratum 
173,174     ☑   Propolis 
175,176       Fabaceae Pueraria lobata 
177  ☑     Lythraceae Punica granatum 
178,179       Orobanchaceae Rehmannia glutinosa 
180     ☑  Polygonaceae Rheum officinale 
118       Crassulaceae Rhodiola rosea 
181  ☑     Lamiaceae Salvia hispanica 
182-184  ☑   ☑  Lamiaceae Salvia miltiorrhiza 
185     ☑  Asteraceae Silybum marianum 
186-188    ☑ ☑ ☑ Myrtaceae Syzyguim cumini (Leaf/Fruit/Seeds/bark/tea) 
189     ☑ ☑ Combretaceae Terminalia chebula (seeds) 
190  ☑   ☑ ☑ Combretaceae Terminalia catappa (Fruit) 
191    ☑   Menispermaceae Tinospora cordifolia 
192,193   ☑    Fabaceae Trigonella foenum graecum 
194   ☑    Ericaceae Vaccinium myrtillus 
185,190,1
96   ☑ ☑ ☑ ☑ Vitaceae Vitis vinifera 
197, 198       Solanaceae Withania somnifera 
199, 200    ☑   Zingiberaceae Zingiber officinal 
 Table 2: Mechanism actions of medicinal plants on diabetes and its complications 
Reference Mechanism Family Scientific name 
168 The antihyperglycemic and nephroprotective effects 
are related to reducing diabetes-induced functional 
and histological alterations in the kidneys and 
reduced accumulation of mucopolysaccharides in the 
kidneys. 
 
Anacardiaceae Anacardium 
occidentale Linn. 
79 The antidiabetic and hypoglycemic effects of this 
plant are associated with increased insulin levels in 
the pancreatic islets, increased glucose consumption 
in the muscles, and inhibition of hepatic glucose 
uptake. 
Annonaceae Annona squamosa 
Linn. 
81 Reduction of oxidative stress on pancreatic Β cells. 
The treatment increased the area of insulin 
immunoreactive Β cells and partially prevented 
degeneration of B-cells 
Annonaceae Annona muricata 
Linn. 
92 The antidiabetic effects of this plant are caused by 
lowering blood glucose levels and increasing insulin 
sensitivity. 
Nyctaginaceae Boerhaavia diffusa 
Linn. 
95 The antihyperglycemic effects induced by this plant 
are due to the increased conversion of glucose to 
glycogen in the kidney and increased insulin 
sensitivity. 
Nyctaginaceae Bougainvillea 
spectabilis Linn.  
201 Antidiabetic effects of this plant 
cells and requires functional B-cell islets 
 
Euphorbiaceae Bridelia ndellensis 
Beille.  
202 The antihyperglycemic and antihyperlipidemic 
effects of this plant are due to its decreasing blood 
glucose and urine levels, as well as its decreasing 
triglyceride, ketone bodies, and cholesterol 
associated with diabetes mellitus. 
 
Leguminosae Canavalia 
ensiformis DC.  
106 The hypoglycemic effects induced by this plant are 
associated with reduced blood glucose levels and 
affecting the metabolism of proteins and marker 
enzymes. 
Flacourtiaceae Casearia esculenta 
Roxb. 
107 Reducing blood glucose levels 
 
Caesalpiniacea
e 
Cassia kleinii Wight 
& Arn. 
203 The mechanism of hypoglycemic action of this plant 
is associated with prophylactic activity against 
necrotic actions. 
Affecting carbohydrate metabolism enzymes. 
Apocyaceae Catharanthus 
roseus Linn. 
Increasing insulin secretion. 
Helping prevent damage due to free radical oxygen 
and exerting antioxidant effects. 
Increasing glucose uptake in tissues 
204 Exerting B-cell restorative properties against alloxan 
induced damage 
 
Cucurbitaceae Coccinia indica 
Wight & Arn. 
126 Exerting antihyperglycemic effects by reducing 
serum glucose levels and increasing glucose 
resistance. 
 
Menispermacea
e 
Cocculus hirsutus 
Linn. 
127 Regulating the metabolism and improving the 
antioxidant effects  
Regulating the glucose homeostasis and reducing 
gluconeogenesis. 
Exerting supportive effect on the antioxidant defense 
of the cell 
Menispermacea
e 
Coscinium 
fenestratum Colebr. 
142 Exerting antihyperlipidemic effects in the body by 
controlling hyperketonemia and 
hypercholesterolemia. 
Dioscoreaceae Dioscorea 
dumetorum Pax. 
144 Reducing fasting blood glucose levels by directly 
influencing beta cells 
Moraceae Ficus hispida Linn. 
156 The mechanism of the hypoglycemic effect of this 
plant has not yet been determined yet. 
Hypoxidaceae Hypoxis 
hemerocallidea 
Fisch. Mey. 
205 Exerting hypoglycemic effects by increasing liver 
glycogen concentration and affecting carbohydrates 
metabolism 
Rutaceae Murraya koenigii 
Linn. 
168 Exerting hypoglycemic effects by affecting the 
metabolism of carbohydrates. 
Araliaceae Panax ginseng 
Linn. 
188 Hypoglycemic effects can be exerted via different 
mechanisms only in disease conditions and in 
diabetic people. 
Myrtaceae Syzyguim cumini 
Linn. 
189 This plant has renoprotective action. Combretaceae Terminalia chebula 
Retz 
190 Exerting antidiabetic and antihyperglycemic effects 
through regeneration of beta cells due to B-carotene 
in reducing diabetic complications like glycosylation 
Combretaceae Terminalia catappa 
Linn. 
 
 
 
 
